Association between vitamin D receptor FokI. Polymorphism and serum parathyroid hormone level in patients with chronic renal failure

J Endocrinol Invest. 2005 Feb;28(2):117-21. doi: 10.1007/BF03345353.

Abstract

We investigated the relationship between vitamin D receptor (VDR) start codon polymorphism and serum levels of PTH, calcidiol, and calcium in 64 Spanish patients with chronic renal failure (CRF). An exon 2 fragment of the VDR gene was amplified by PCR, and cleaved with the restriction enzyme FokI. The alleles were identified according to the digestion pattern obtained as F (absence of restriction site) and f (presence of restriction site). Genotype frequencies in the patient population were 54.7% FF, 28.1% Ff and 17.2% ff, vs 46.7% FF, 43.3% Ff and 10% ff in a healthy control population. The difference between the two populations was statistically significant (p<0.01). Within the patient population, mean serum PTH level in the FF group was significantly higher (159.77+/-25.69 pg/ml) than in both the Ff and ff groups (106.67+/-19.07 and 77.55+/-15.85 pg/ml, respectively; p<0.05). However there were no significant differences in serum levels of calcidiol or calcium among genotypes. These results suggest that FokI polymorphisms of the VDR gene may determine parathyroid response in CRF patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcifediol / blood
  • Calcium / blood
  • Deoxyribonucleases, Type II Site-Specific / pharmacology*
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / genetics*
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood*
  • Polymorphism, Genetic*
  • Receptors, Calcitriol / drug effects*
  • Receptors, Calcitriol / genetics*

Substances

  • Parathyroid Hormone
  • Receptors, Calcitriol
  • endodeoxyribonuclease FokI
  • Deoxyribonucleases, Type II Site-Specific
  • Calcifediol
  • Calcium